SHANGHAI, Aug. 30, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has ...
Transferring a biologic candidate from the research and development phase to commercial production usually requires increasing the working volume of the upstream bioprocess. During scale-up, process ...
Bench-Scale Bioreactors Incorporate Single-Use Elements, Linearly Scalable Actuators, and Sensors Bench-scale bioreactors ranging in volume from about 2 L to 20 L have become indispensable as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback